The financial burden of anthrax treatment varies widely by severity, location, and healthcare system. Uncomplicated cutaneous anthrax, treated early with oral antibiotics, may cost a few thousand dollars and is often largely covered by insurance. However, severe inhalational, gastrointestinal, or injectional anthrax requiring ICU care, prolonged IV antibiotics, advanced imaging, possible surgery, and weeks of hospitalization can quickly reach tens to hundreds of thousands of dollars, especially in high-income countries. In many regions, insurance or national health systems cover most medically necessary care, though patients may still face deductibles, copays, or uncovered costs related to long ICU stays or specialized procedures. Public health emergencies may also trigger government coverage or reimbursement, reducing out-of-pocket expenses.